Effects of CS-1 on A431 cell proliferation, cell cycle, and epidermal growth factor receptor signal transduction

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 2, 2012, Pages 136-146

  Du, Haiyan ^a,b   Xu, Bo ^a   Wu, Caixia ^c   Li, Min ^a   Ran, Fuxiang ^a   Cai, Shaoqing ^d   Cui, Jingrong ^a  

^a PEKING UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Shandong Medical College   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

cell cycle; CS 1; EGFR signaling pathway; high content screening

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; CCND1 PROTEIN, HUMAN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; HERBACEOUS AGENT; PROTEIN KINASE B; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHINESE MEDICINE; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; DRUGS, CHINESE HERBAL; HUMANS; MAP KINASE SIGNALING SYSTEM; MEDICINE, CHINESE TRADITIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84863068413     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr111     Document Type: Article

References (10)

1. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A and Paradiso A. The complexity of targeting EGFR signalling in cancer: From expression to turnover. Biochim Biophys Acta 2006, 1766: 120-139.
2. Jorissen RN, Walker F, Pouliot N, Garrett TPJ, Ward CW and Burgess AW. Epidermal growth factor receptor: Mechanisms of activation and signaling. Exp Cell Res 2003, 284: 31-53.
3. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103: 211-225.
4. Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991, 47: 87-98.
5. Masui H, Kawamoto T, Sato JD, Wolf B, Sato G and Mendelsohn J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 1984, 44: 1002-1007.
6. van de Vijver MJ, Kumar R and Mendelsohn J. Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J Biol Chem 1991, 266: 7503-7508.
7. Sun Y, Fry DW, Vincent P, Nelson JM, Elliott W and Leopold WR. Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors. Anticancer Res 1999, 19: 919-924.
8. Zhu XF, Liu ZC, Xie BF, Li ZM, Feng GK, Yang DJ and Zeng YX. EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells. Cancer Lett 2001, 169: 27-32.
9. Busse D, Doughty RS, Ramsey TT, Russel WE, Price JO, Flanagan WM and Shawver LK, et al. Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27kip1 independent of MAPK activity. J Biol Chem 2000, 275: 6987-6995.
10. Widmann C, Gibson S, Jarpe MB and Johnson GL. Mitogen activated protein kinase: Conservation of a three kinase module from yeast to human. Physiol Rev 1999, 79: 143-180.